543 results on '"Chinot, O."'
Search Results
2. Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
3. Innovative treatments for meningiomas
4. Tumeurs cérébrales, gliomes malins
5. Molecular and clinical diversity in primary central nervous system lymphoma
6. Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature
7. Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial
8. (R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study
9. Tumeurs gliales intramédullaires de l’adulte : la série du rapport
10. Contribution of nuclear medicine to the diagnosis and management of primary brain tumours
11. Évaluation préopératoire comparative de 43 gliomes de grade II et III par TEP au 18F-FDG et à la 18F-DOPA : corrélation aux données histologiques et moléculaires
12. Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
13. KS05.6.A Oral DNA vaccination targeting VEGFR2 combined with the anti-PD-L1 antibody avelumab in patients with progressive glioblastoma - final results. NCT03750071
14. OS07.3.A Phase 1/2 clinical trial of blood-brain barrier opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients receiving IV carboplatin
15. P09.03.A Associations of levetiracetam use with the safety and tolerability of chemoradiotherapy for patients with newly diagnosed glioblastoma
16. IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas
17. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
18. Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
19. Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life
20. Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome
21. High-grade glioma in elderly patients: can the oncogeriatrician help?
22. Surgical management
23. Nouvelles approches théranostiques pour la prise en charge des méningiomes
24. P04.08 Biopsy-only glioblastoma (BO-GBM) as a heterogeneous group of patients
25. PL03.1.A Surgery for glioblastomas in the elderly: an ANOCEF trial (CSA)
26. KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI)
27. P11.04 Autonomy duration as analyzed by KPS≥70 cumulative time in patients with biopsy-only glioblastoma (BO-GBM). A sub-analysis of the Timone cohort
28. PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
29. Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen
30. Chimiothérapie et traitements ciblés des glioblastomes
31. Supplement to: Bevacizumab plus radiotherapy—temozolomide for newly diagnosed glioblastoma.
32. 546P Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
33. Intérêt de l’association bévacizumab/irinotécan dans le traitement des glioblastomes. Une étude multicentrique de l’ANOCEF
34. Measuring change in health-related quality of life
35. Challenges in diagnosis and management of adult spinal cord gliomas
36. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
37. Implications pronostiques de différents marqueurs biologiques dans les méningiomes intracrâniens : à propos de 120 cas
38. Intérêt de la mesure du volume sanguin régional cérébral relatif par IRM de perfusion dans la prise en charge des gliomes
39. Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d’une étude multicentrique de l’Anocef
40. Glioblastomes: aspects moléculaires et prise en charge actuelle
41. Identification of secondary structure in the 5′-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation
42. The role of Gamma Knife radiosurgery in the treatment of pineal parenchymal tumours
43. Épendymomes intracrâniens de l'adulte. Diagnostic histologique et facteurs histopronostiques
44. Épendymomes intracrâniens de l'adulte. Analyse rétrospective de 121 cas provenant de l'étude multicentrique française
45. When appearances are misleading: About one case of primary central nervous system lymphoma (PCNSL)
46. Joint SFMN/ANOCEF focus on 18F-FDOPA PET imaging in glioma: Current applications and perspectives
47. Characteristics and patterns of care of high-grade IDH-mutant gliomas in elderly patients: A French POLA network study
48. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme
49. Place de la chimiothérapie et de la radiothérapie dans le traitement des oligodendrogliomes
50. Abstracts of posters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.